Antiobesity effect of eicosapentaenoic acid in high-fat/high-sucrose diet-induced obesity: importance of hepatic lipogenesis.
about
Preservation of metabolic flexibility in skeletal muscle by a combined use of n-3 PUFA and rosiglitazone in dietary obese miceOmega-3s and cardiovascular health.Oil from the marine zooplankton Calanus finmarchicus improves the cardiometabolic phenotype of diet-induced obese miceWax esters from the marine copepod Calanus finmarchicus reduce diet-induced obesity and obesity-related metabolic disorders in miceMetabolic effects of n-3 PUFA as phospholipids are superior to triglycerides in mice fed a high-fat diet: possible role of endocannabinoidsA mouse model of diet-induced obesity and insulin resistanceSucrose counteracts the anti-inflammatory effect of fish oil in adipose tissue and increases obesity development in miceRat chromosome 8 confers protection against dyslipidemia caused by a high-fat/low-carbohydrate diet.Ameliorative effect of myricetin on insulin resistance in mice fed a high-fat, high-sucrose diet.Rodent models for metabolic syndrome research.Novel Inhibitory Effects of Glycyrrhizic Acid on the Accumulation of Advanced Glycation End Product and Its Receptor Expression.A model of metabolic syndrome and related diseases with intestinal endotoxemia in rats fed a high fat and high sucrose diet.Eicosapentaenoic acid ameliorates non-alcoholic steatohepatitis in a novel mouse model using melanocortin 4 receptor-deficient miceEicosapentaenoic and docosahexaenoic acid-enriched high fat diet delays the development of fatty liver in miceEffect of a high fat, high sucrose diet on the promotion of non-alcoholic fatty liver disease in male rats: the ameliorative role of three natural compounds.Different Effects of Eicosapentaenoic and Docosahexaenoic Acids on Atherogenic High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Mice.Fish oil and indomethacin in combination potently reduce dyslipidemia and hepatic steatosis in LDLR(-/-) mice.Mitochondrial dysfunction and activation of iNOS are responsible for the palmitate-induced decrease in adiponectin synthesis in 3T3L1 adipocytes.Long-term dietary supplementation with saury oil attenuates metabolic abnormalities in mice fed a high-fat diet: combined beneficial effect of omega-3 fatty acids and long-chain monounsaturated fatty acids.Multidisciplinary pharmacotherapeutic options for nonalcoholic Fatty liver disease.Impact of L-FABP and glucose on polyunsaturated fatty acid induction of PPARα-regulated β-oxidative enzymes.Effects of microalgal polyunsaturated fatty acid oil on body weight and lipid accumulation in the liver of C57BL/6 mice fed a high fat diet.High glucose potentiates L-FABP mediated fibrate induction of PPARα in mouse hepatocytes.Recent advances in obesity-induced inflammation and insulin resistance.Omega-3 fatty acids and incident type 2 diabetes: a systematic review and meta-analysis.Green tea extract containing a highly absorbent catechin prevents diet-induced lipid metabolism disorderEffects of dietary eicosapentaenoic acid (EPA) supplementation in high-fat fed mice on lipid metabolism and apelin/APJ system in skeletal muscle.Highly purified eicosapentaenoic acid ameliorates cardiac injury and adipose tissue inflammation in a rat model of metabolic syndrome.Effects of Lycium barbarum. polysaccharide on type 2 diabetes mellitus rats by regulating biological rhythms.In vivo bioluminescence imaging reveals copper deficiency in a murine model of nonalcoholic fatty liver disease.Molecular phenotyping of multiple mouse strains under metabolic challenge uncovers a role for Elovl2 in glucose-induced insulin secretion.Wheat alkylresorcinols suppress high-fat, high-sucrose diet-induced obesity and glucose intolerance by increasing insulin sensitivity and cholesterol excretion in male mice.Elovl2 ablation demonstrates that systemic DHA is endogenously produced and is essential for lipid homeostasis in mice.Eicosapentaenoic acid down-regulates expression of the selenoprotein P gene by inhibiting SREBP-1c protein independently of the AMP-activated protein kinase pathway in H4IIEC3 hepatocytes.Alterations of specific lipid groups in serum of obese humans: a review.Plasma ω-3 fatty acids in pregnancy are inversely associated with postpartum weight retention in a multiethnic Asian cohort.8-Hydroxyeicosapentaenoic Acid Decreases Plasma and Hepatic Triglycerides via Activation of Peroxisome Proliferator-Activated Receptor Alpha in High-Fat Diet-Induced Obese MiceIn rats fed high-energy diets, taste, rather than fat content, is the key factor increasing food intake: a comparison of a cafeteria and a lipid-supplemented standard diet.Eicosapentaenoic acid shows anti-inflammatory effect via GPR120 in 3T3-L1 adipocytes and attenuates adipose tissue inflammation in diet-induced obese mice.Sea cucumber and blue mussel: new sources of phospholipid enriched omega-3 fatty acids with a potential role in 3T3-L1 adipocyte metabolism.
P2860
Q27322378-349A6B80-58B7-4A05-8F7F-72C3D6368E5AQ27686781-CB4BC41C-C7C5-4519-B152-46181A6AA17EQ28292819-D3CEFAA1-393D-407C-A135-D0593CF1FC02Q28302954-8DBE78C1-4999-47EB-918C-2398C392D7D2Q28728625-BD075F75-5BDA-4175-9DAF-7AC42668F470Q30410077-BB7892E5-AF75-45DB-9080-714B951AEDB6Q33955225-BED069A5-CC6C-4E47-A32C-504CF98D1688Q34206069-143709A4-4487-4DD7-BDC0-7DDEC85725A3Q34347888-4C753C7B-FDEF-4B4B-B152-189D6A454097Q34479248-08CBED77-36B6-4D44-A46E-E7B315FC717BQ34604583-86DFFBD4-C923-4A9E-9F4B-3834A237B6B4Q35515672-DE7B0B4A-78E3-45B1-970B-5A14FB1953FCQ35588868-689605E8-1646-4A60-9194-04C384214B15Q35700655-F1AB9936-DC89-4356-BF41-48BF4D4C781AQ35903361-8F200E98-8EA7-4E76-A294-6E26F4B5632DQ36059065-6B2D8792-F0B1-4F1E-B671-D02068A5AED1Q36213911-62250221-A2E4-4144-878C-6BCC31E36DC9Q36301880-D64492C7-5EBB-4F62-AAAD-F9D8DA919568Q36337183-8BBD8E10-25DF-4D36-8496-0A7902E037E2Q36470320-70548B8A-0E9B-425D-B4DF-6839255371A6Q36593126-A19976CF-1361-4BC3-A44F-19978851202EQ36947219-40CE5444-1D14-4176-A8F3-30DE337A3FB3Q37062345-301C5EBE-9784-496C-A0EA-9E555E4B8000Q37080182-692CB038-B820-4997-A4D2-9A20812D358EQ37098566-8B00E552-8360-46C9-A668-96F0BC346E22Q37197043-F7243B7C-6233-485D-A792-DDEA1CC60601Q37288696-96E3A857-21D1-4F7A-AE0F-54ECA2E03FD9Q37299065-1D1AA194-49B1-4C47-95FE-7E3A70856160Q37366426-84993A60-3282-45F6-8CDB-4CDFDABF268BQ37514940-A8C4ACAE-4F55-4B53-8BF8-BE1BE6D721E0Q37724749-2D1A1DD8-F9FF-4CA1-810A-BEEC6834F481Q38301296-D77ABE5A-1005-4EB7-BF62-132CDC2ABE82Q38528762-42B6E1C5-358B-4B0B-AEEF-6E7C6EE88372Q38705146-57A29FCE-EA1C-4424-B1FE-144A831A5A11Q39023727-921FF275-0515-4CB0-A9B9-2D0D103315DFQ40279479-71F88E3A-15A0-4975-BCB0-5BEA642B15C5Q41446052-BFBB8CB6-D531-42C3-B93A-D06E376B7835Q41722970-A35F8726-62C1-474F-B34F-11E51D12E9BBQ42283305-95A20F5A-F44B-495A-9C26-CEA2E421B0BEQ42834172-BF2A1362-A58F-4AD2-946C-9EE55FD765CB
P2860
Antiobesity effect of eicosapentaenoic acid in high-fat/high-sucrose diet-induced obesity: importance of hepatic lipogenesis.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Antiobesity effect of eicosape ...... rtance of hepatic lipogenesis.
@ast
Antiobesity effect of eicosape ...... rtance of hepatic lipogenesis.
@en
type
label
Antiobesity effect of eicosape ...... rtance of hepatic lipogenesis.
@ast
Antiobesity effect of eicosape ...... rtance of hepatic lipogenesis.
@en
prefLabel
Antiobesity effect of eicosape ...... rtance of hepatic lipogenesis.
@ast
Antiobesity effect of eicosape ...... rtance of hepatic lipogenesis.
@en
P2093
P2860
P356
P1433
P1476
Antiobesity effect of eicosape ...... rtance of hepatic lipogenesis.
@en
P2093
Ayumi Sato
Hiroyuki Kawano
Kiyoshi Mizuguchi
Masahiko Ohta
Masanori Nakakuki
Michiko Itoh
Takayoshi Suganami
Tatsuto Notsu
Yoshihiro Ogawa
P2860
P304
P356
10.2337/DB09-1554
P407
P577
2010-08-03T00:00:00Z